Close
4

Athena Athena

X

Find Insulin Glargine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

Looking for / Insulin Glargine API manufacturers, exporters & distributors?

Insulin Glargine manufacturers, exporters & distributors 1

14

PharmaCompass offers a list of Insulin Glargine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Insulin Glargine manufacturer or Insulin Glargine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Insulin Glargine manufacturer or Insulin Glargine supplier.

PharmaCompass also assists you with knowing the Insulin Glargine API Price utilized in the formulation of products. Insulin Glargine API Price is not always fixed or binding as the Insulin Glargine Price is obtained through a variety of data sources. The Insulin Glargine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Insulin Glargine

Synonyms

Gtpl7572, Hoe901, Hoe-901

About Insulin Glargine

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Glargine Manufacturers

A Glargine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glargine, including repackagers and relabelers. The FDA regulates Glargine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glargine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Glargine Suppliers

A Glargine supplier is an individual or a company that provides Glargine active pharmaceutical ingredient (API) or Glargine finished formulations upon request. The Glargine suppliers may include Glargine API manufacturers, exporters, distributors and traders.

click here to find a list of Glargine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Glargine USDMF

A Glargine DMF (Drug Master File) is a document detailing the whole manufacturing process of Glargine active pharmaceutical ingredient (API) in detail. Different forms of Glargine DMFs exist exist since differing nations have different regulations, such as Glargine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Glargine DMF submitted to regulatory agencies in the US is known as a USDMF. Glargine USDMF includes data on Glargine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glargine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Glargine suppliers with USDMF on PharmaCompass.

Glargine JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Glargine Drug Master File in Japan (Glargine JDMF) empowers Glargine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Glargine JDMF during the approval evaluation for pharmaceutical products. At the time of Glargine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Glargine suppliers with JDMF on PharmaCompass.

Glargine WC

A Glargine written confirmation (Glargine WC) is an official document issued by a regulatory agency to a Glargine manufacturer, verifying that the manufacturing facility of a Glargine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glargine APIs or Glargine finished pharmaceutical products to another nation, regulatory agencies frequently require a Glargine WC (written confirmation) as part of the regulatory process.

click here to find a list of Glargine suppliers with Written Confirmation (WC) on PharmaCompass.

Glargine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glargine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Glargine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Glargine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Glargine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glargine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Glargine suppliers with NDC on PharmaCompass.

Glargine GMP

Glargine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Glargine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glargine GMP manufacturer or Glargine GMP API supplier for your needs.

Glargine CoA

A Glargine CoA (Certificate of Analysis) is a formal document that attests to Glargine's compliance with Glargine specifications and serves as a tool for batch-level quality control.

Glargine CoA mostly includes findings from lab analyses of a specific batch. For each Glargine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Glargine may be tested according to a variety of international standards, such as European Pharmacopoeia (Glargine EP), Glargine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glargine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY